EW vs TPCS · P/E 47, rev $1.39B vs rev $34.0M
Edwards Lifesciences Corp (EW) versus TechPrecision Corporation Common stock (TPCS) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
TechPrecision Corporation Common stock (TPCS) is a metal fabrication company listed on NASDAQ.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported TPCS revenue for 2025-03-31 was $34.0M. Net income was -$2.7M. Revenue was up 7.7% from 2024-03-31 to 2025-03-31. TPCS currently screens at market cap $34.5M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. TPCS currently screens at market cap $34.5M.
Not investment advice. Open the EW and TPCS stock pages for the full models.
Not investment advice.